237 related articles for article (PubMed ID: 20554863)
1. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum.
De Chiara V; Angelucci F; Rossi S; Musella A; Cavasinni F; Cantarella C; Mataluni G; Sacchetti L; Napolitano F; Castelli M; Caltagirone C; Bernardi G; Maccarrone M; Usiello A; Centonze D
J Neurosci; 2010 Jun; 30(24):8127-37. PubMed ID: 20554863
[TBL] [Abstract][Full Text] [Related]
2. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum.
De Chiara V; Errico F; Musella A; Rossi S; Mataluni G; Sacchetti L; Siracusano A; Castelli M; Cavasinni F; Bernardi G; Usiello A; Centonze D
Neuropsychopharmacology; 2010 Jan; 35(2):374-87. PubMed ID: 19776732
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum.
De Chiara V; Motta C; Rossi S; Studer V; Barbieri F; Lauro D; Bernardi G; Centonze D
Neuroscience; 2013 Oct; 250():232-9. PubMed ID: 23856068
[TBL] [Abstract][Full Text] [Related]
4. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.
Castelli M; Federici M; Rossi S; De Chiara V; Napolitano F; Studer V; Motta C; Sacchetti L; Romano R; Musella A; Bernardi G; Siracusano A; Gu HH; Mercuri NB; Usiello A; Centonze D
Eur J Neurosci; 2011 Nov; 34(9):1369-77. PubMed ID: 22034972
[TBL] [Abstract][Full Text] [Related]
5. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum.
Rossi S; De Chiara V; Musella A; Kusayanagi H; Mataluni G; Bernardi G; Usiello A; Centonze D
J Neurosci; 2008 Jul; 28(29):7284-92. PubMed ID: 18632932
[TBL] [Abstract][Full Text] [Related]
6. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors.
Centonze D; Rossi S; De Chiara V; Prosperetti C; Battista N; Bernardi G; Mercuri NB; Usiello A; Maccarrone M
Eur J Neurosci; 2007 Mar; 25(6):1631-40. PubMed ID: 17408430
[TBL] [Abstract][Full Text] [Related]
7. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling.
Pan B; Hillard CJ; Liu QS
J Neurosci; 2008 Dec; 28(52):14018-30. PubMed ID: 19109485
[TBL] [Abstract][Full Text] [Related]
8. BDNF-endocannabinoid interactions at neocortical inhibitory synapses require phospholipase C signaling.
Zhao L; Levine ES
J Neurophysiol; 2014 Mar; 111(5):1008-15. PubMed ID: 24335212
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex.
Chiu CQ; Puente N; Grandes P; Castillo PE
J Neurosci; 2010 May; 30(21):7236-48. PubMed ID: 20505090
[TBL] [Abstract][Full Text] [Related]
10. BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons.
Zhong P; Liu Y; Hu Y; Wang T; Zhao YP; Liu QS
J Neurosci; 2015 Mar; 35(10):4469-81. PubMed ID: 25762688
[TBL] [Abstract][Full Text] [Related]
11. Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.
Daigle TL; Wetsel WC; Caron MG
Eur J Neurosci; 2011 Nov; 34(9):1378-89. PubMed ID: 22034973
[TBL] [Abstract][Full Text] [Related]
12. Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance.
Dubreucq S; Durand A; Matias I; Bénard G; Richard E; Soria-Gomez E; Glangetas C; Groc L; Wadleigh A; Massa F; Bartsch D; Marsicano G; Georges F; Chaouloff F
Biol Psychiatry; 2013 May; 73(9):895-903. PubMed ID: 23237313
[TBL] [Abstract][Full Text] [Related]
13. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA.
Maccarrone M; Rossi S; Bari M; De Chiara V; Rapino C; Musella A; Bernardi G; Bagni C; Centonze D
Neuropsychopharmacology; 2010 Jun; 35(7):1500-9. PubMed ID: 20393458
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
Laprairie RB; Kelly ME; Denovan-Wright EM
Neuropharmacology; 2013 Sep; 72():47-57. PubMed ID: 23602984
[TBL] [Abstract][Full Text] [Related]
15. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice.
Centonze D; Rossi S; Prosperetti C; Tscherter A; Bernardi G; Maccarrone M; Calabresi P
Biol Psychiatry; 2005 Jun; 57(12):1583-9. PubMed ID: 15953496
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum.
Tebano MT; Martire A; Chiodi V; Pepponi R; Ferrante A; Domenici MR; Frank C; Chen JF; Ledent C; Popoli P
J Neurochem; 2009 Sep; 110(6):1921-30. PubMed ID: 19627447
[TBL] [Abstract][Full Text] [Related]
17. The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum.
Centonze D; Rossi S; Napoli I; Mercaldo V; Lacoux C; Ferrari F; Ciotti MT; De Chiara V; Prosperetti C; Maccarrone M; Fezza F; Calabresi P; Bernardi G; Bagni C
J Neurosci; 2007 Aug; 27(33):8885-92. PubMed ID: 17699670
[TBL] [Abstract][Full Text] [Related]
18. Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants.
Corbillé AG; Valjent E; Marsicano G; Ledent C; Lutz B; Hervé D; Girault JA
J Neurosci; 2007 Jun; 27(26):6937-47. PubMed ID: 17596442
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum.
Orrú M; Quiroz C; Guitart X; Ferré S
Neuropharmacology; 2011; 61(5-6):967-74. PubMed ID: 21752341
[TBL] [Abstract][Full Text] [Related]
20. Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition.
Lu H; Cheng PL; Lim BK; Khoshnevisrad N; Poo MM
Neuron; 2010 Sep; 67(5):821-33. PubMed ID: 20826313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
